Relationship between ADD1 Gly460Trp gene polymorphism and essential hypertension in Madeira Island-Reference-Cited by-同舟云学术

Relationship between ADD1 Gly460Trp gene polymorphism and essential hypertension in Madeira Island

Published:2017-10 Issue:42 Volume:96 Page:e7861
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Sousa Ana Célia,Palma dos Reis Roberto,Pereira Andreia,Borges Sofia,Freitas Ana Isabel,Guerra Graça,Góis Teresa,Rodrigues Mariana,Henriques Eva,Freitas Sónia,Ornelas Ilídio,Pereira Décio,Brehm António,Mendonça Maria Isabel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference28 articles.

1. Global burden of hypertension: analysis of worldwide data;Kearney;Lancet,2005

2. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study;Polonia;J Hypertens,2014

3. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies;Lewington;Lancet,2002

4. The genetics of essential hypertension;O'Shaughnessy;Br J Clin Pharmacol,2001

5. Molecular genetics of human hypertension;Gong;Clin Sci,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single nucleotide polymorphism rs4961 in the adducin 1 gene is not associated with gastric cancer or preneoplastic cancer lesions;Oncology Letters;2024-07-24

2. The Association between Gly460Trp-Polymorphism of Alpha-Adducin 1 Gene (ADD1) and Arterial Hypertension Development in Ukrainian Population;International Journal of Hypertension;2021-05-04

3. Three Novel Genetic Variants in the FAM110D, CACNA1A, and NLRP12 Genes Are Associated With Susceptibility to Hypertension Among Dai People;American Journal of Hypertension;2021-02-23

4. New Genetic Polymorphisms as Epidemiological Factor of Arterial Hypertension in Patients with Hyposodical Diet;Current Hypertension Reviews;2021-02-04

5. Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges;AAPS PharmSciTech;2020-01-06